Sophia (Sujin) Kim 7/25/25 Sophia (Sujin) Kim 7/25/25

Significant Shareholding Disclosure Report

KR / EN

Significant Shareholding Disclosure Report - KR / EN

Sophia (Sujin) Kim 7/16/25 Sophia (Sujin) Kim 7/16/25

Notice of Shareholders Meeting

KR / EN

Notice of Shareholders Meeting - KR / EN

Sophia (Sujin) Kim 7/10/25 Sophia (Sujin) Kim 7/10/25

[Amendment Report]Resolutions to Convene a General Meeting of Shareholders

KR / EN

[Amendment Report]Resolutions to Convene a General Meeting of Shareholders - KR / EN

Sophia (Sujin) Kim 6/25/25 Sophia (Sujin) Kim 6/25/25

Setting the Record Date (Share Register)

KR / EN

In accordance with Article 354 of the Korean Commercial Act and Article 14 of the Articles of Incorporation of Orum Therapeutics Inc., we hereby announce the record date as outlined below to determine shareholders eligible to exercise voting rights at the upcoming extraordinary general meeting.

1. Record Date (Shareholder Determination Date): July 10, 2025 (July 17, 2025)

2. Purpose: To determine the shareholders entitled to vote at the upcoming extraordinary general meeting.

Date: June 25, 2025

Orum Therapeutics Inc.

281-25 Munji-ro, Yuseong-gu, Daejeon, Korea

CEO Sung Joo Lee

Transfer Agent

Korea Securities Depository

CEO Soonho Lee

Setting the Record Date (Share Register) : KR / EN